Pharma Journalist -

Cadrenal Therapeutics, Inc., a biopharmaceutical company focused on innovative anticoagulation therapies, has announced the acquisition of eXIthera Pharmaceuticals’ portfolio of Factor…
Read More...

aTyr Pharma, Inc. a clinical-stage biotech company developing first-in-class therapeutics from its proprietary tRNA synthetase platform, today announced topline results from its Phase 3…
Read More...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved an update to the label of Novo Nordisk’s oral diabetes drug Rybelsus (oral…
Read More...

Amneal Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for sodium oxybate oral solution 500 mg/mL, a…
Read More...

Boston, MA (September 22, 2025) & Washington, D.C. (November 6, 2025). The LEAN Cell & Gene Summit series, co-organised by ScaleReady, and Hanson Wade, is proud to unveil its…
Read More...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s investigational gene therapy SAR402663 for treating neovascular age-related macular…
Read More...

Charles River Laboratories International, Inc. has announced two strategic partnerships aimed at advancing oncology research and accelerating the development of novel cancer therapies.…
Read More...

Zentiva, a leading European generics pharmaceutical company, has been sold by Advent International to GTCR, two major global private equity firms announced today. Advent acquired…
Read More...

The Chinese National Medical Products Administration (NMPA) has approved Tzield (teplizumab) as the country’s first disease-modifying therapy for autoimmune type 1 diabetes (T1D). The…
Read More...

Kriya Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering gene therapies for chronic diseases, has announced the closing of a $320 million Series D financing. The…
Read More...